Search research articles
Contact Us
Filters
Showing results (181-190 of 188) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 188 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 2025
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial
D Ciardiello, G Martini, L Boscolo Bielo, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
<i>HER-2</i> gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study
D Ciardiello, L Boscolo Bielo, S Napolitano, et al.
ESMO Open
|
June 24, 2025
Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial
D Ciardiello, L Boscolo Bielo, F Pietrantonio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2012
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making
H J Schmoll, E Van Cutsem, A Stein, et al.
ESMO Open
|
March 19, 2025
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial
D Ciardiello, L Boscolo Bielo, S Napolitano, et al.
ESMO Open
|
October 29, 2025
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy
L Boscolo Bielo, S Napolitano, A Avallone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2016
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E Van Cutsem, A Cervantes, R Adam, et al.
ESMO Open
|
August 30, 2017
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial
E Martinelli, C Cardone, T Troiani, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 188) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 188 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 2025
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial
D Ciardiello, G Martini, L Boscolo Bielo, et al.
ESMO Gastrointestinal Oncology
|
April 17, 2026
<i>HER-2</i> gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study
D Ciardiello, L Boscolo Bielo, S Napolitano, et al.
ESMO Open
|
June 24, 2025
Comprehensive genomic profiling by liquid biopsy in refractory metastatic colorectal cancer patients who are candidate for anti-EGFR rechallenge therapy: findings from the CAVE-2 GOIM trial
D Ciardiello, L Boscolo Bielo, F Pietrantonio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2012
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making
H J Schmoll, E Van Cutsem, A Stein, et al.
ESMO Open
|
March 19, 2025
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial
D Ciardiello, L Boscolo Bielo, S Napolitano, et al.
ESMO Open
|
October 29, 2025
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy
L Boscolo Bielo, S Napolitano, A Avallone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 7, 2016
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E Van Cutsem, A Cervantes, R Adam, et al.
ESMO Open
|
August 30, 2017
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial
E Martinelli, C Cardone, T Troiani, et al.
Page
of 19